Standout Papers

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of <i>HER2</i>-Ov... 2002 2026 2010 2018 1.5k
  1. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer (2002)
    Charles L. Vogel, Melody Cobleigh et al. Journal of Clinical Oncology

Immediate Impact

6 by Nobel laureates 29 from Science/Nature 68 standout
Sub-graph 1 of 20

Citing Papers

CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
2022 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
2 intermediate papers

Works of Michael Burchmore being referenced

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout

Author Peers

Author Last Decade Papers Cites
Michael Burchmore 1540 894 647 9 2.0k
Sharon A. Baughman 1627 1193 919 10 2.3k
Maureen Murphy 2255 1167 691 6 2.9k
Judit Anido 1262 578 730 12 1.7k
Amol Tandon 1346 697 876 16 2.0k
Thomas Holbro 1236 667 1278 17 2.2k
C Wright 1167 556 556 14 1.6k
Nancy T. Sklarin 1548 767 766 36 2.2k
Keng‐Hsueh Lan 1515 755 1481 21 2.5k
Kristine S. Klos 1636 717 1538 16 2.6k
WJ Gullick 1119 541 748 26 1.6k

All Works

Loading papers...

Rankless by CCL
2026